Literature DB >> 8069565

Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.

W Lin1, A G Coombes, M C Davies, S S Davis, L Illum.   

Abstract

Human serum albumin (HSA) nanospheres of about 100 nm diameter were prepared using a pH-coacervation method whereby acetone was added to an HSA solution (pH 9.0). The particles obtained were cross-linked by glutaraldehyde. Increasing the pH of the HSA solution resulted in a gradual rise in the particle size of the resultant nanospheres. A higher cross-linking efficiency was obtained with increased glutaraldehyde concentration and cross-linking time. No significant differences in surface properties, as determined by zeta potential measurements, were recorded between particles prepared from HSA solutions with different pH. The nanospheres were quite stable over 4 days in both phosphate buffer saline (PBS) solution (pH 7.4) and rat serum, but degraded rapidly over 6 hours when incubated in PBS solution containing trypsin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8069565     DOI: 10.3109/10611869308996081

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  23 in total

Review 1.  Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?

Authors:  Roudayna Diab; Chiraz Jaafar-Maalej; Hatem Fessi; Philippe Maincent
Journal:  AAPS J       Date:  2012-07-06       Impact factor: 4.009

2.  Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles.

Authors:  P Vijayaraj Kumar; Narendr K Jain
Journal:  AAPS PharmSciTech       Date:  2007-03-02       Impact factor: 3.246

Review 3.  Nanoparticulate systems for growth factor delivery.

Authors:  Sufeng Zhang; Hasan Uludağ
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

4.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

Review 5.  Biopolymeric nanoparticles.

Authors:  Sushmitha Sundar; Joydip Kundu; Subhas C Kundu
Journal:  Sci Technol Adv Mater       Date:  2010-02-26       Impact factor: 8.090

6.  Redox-sensitive cross-linking enhances albumin nanoparticle function as delivery system for photodynamic cancer therapy.

Authors:  Anna M Molina; Moraima Morales-Cruz; Marimar Benítez; Kiara Berríos; Cindy M Figueroa; Kai Griebenow
Journal:  J Nanomed Nanotechnol       Date:  2015-05-22

7.  Silylated precision particles for controlled release of proteins.

Authors:  Khosrow Khodabandehlou; Amar S Kumbhar; Sohrab Habibi; Ashish A Pandya; J Christopher Luft; Saad A Khan; Joseph M DeSimone
Journal:  ACS Appl Mater Interfaces       Date:  2015-03-05       Impact factor: 9.229

8.  Preparation of Curcumin Loaded Egg Albumin Nanoparticles Using Acetone and Optimization of Desolvation Process.

Authors:  D S Aniesrani Delfiya; K Thangavel; D Amirtham
Journal:  Protein J       Date:  2016-04       Impact factor: 2.371

Review 9.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

10.  Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.

Authors:  Guilin Wang; Kevin Siggers; Sufeng Zhang; Hongxing Jiang; Zhenghe Xu; Ronald F Zernicke; John Matyas; Hasan Uludağ
Journal:  Pharm Res       Date:  2008-08-15       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.